A Low‐Dose Immunization Schedule for the Production of ALG in Rabbits. | Zendy

AXELSEN N. H. | Zendy; CLAESSON M. H. | Zendy; HARDT F. | Zendy; RANLØV P. | Zendy; RöPKE C. | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Premium

A Low‐Dose Immunization Schedule for the Production of ALG in Rabbits.

Author(s) -

AXELSEN N. H.,

CLAESSON M. H.,

HARDT F.,

RANLØV P.,

RöPKE C.

Publication year - 1972

Publication title -

scandinavian journal of immunology

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.934

H-Index - 88

eISSN - 1365-3083

pISSN - 0300-9475

DOI - 10.1111/j.1365-3083.1972.tb00589.x

Subject(s) - immunization , adjuvant , potency , antibody , immunology , limiting , antigen , medicine , pharmacology , biology , in vitro , biochemistry , mechanical engineering , engineering

ALG was produced in rabbits by intracutaneous injections of small doses (10 6 cells) of C 3 H mouse thymocytes suspended in Freund's incomplete adjuvant. The immunosuppressive potency of this ‘low‐dose’ ALG evaluated by allo‐skin graft survival proved to be comparable to that of ALG produced by intravenous injection of high doses of lymphoid cells (ad modum Levey & Medawar). In addition the ‘low‐dose’ method gave rise to negligible amounts of haemagglutinins, lymphagglutinins, and lymphocytotoxic antibodies. The ‘low‐dose’ method may represent a major advantage in overcoming the limiting factor presented by scarcity of available antigen, which is regularly the case in human ALG production.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here

Accelerating Research